Perspectives
Getting naloxone in the hands of high-risk members
Pharmacists targeted high-risk members at point of sale
February 1, 2019When pharmacists reached out to members picking up an opioid prescription to give them information about naloxone, targeting them at the pharmacy proved impactful.
We knew that members with opioid prescriptions weren’t getting enough information about opioid risks. For this study, Prime used its controlled substance (CS) scoring system to identify members at high risk for opioid overdose and death. When targeted members with high CS scores picked up an opioid prescription, a Walgreens pharmacist provided an Opioid Safety Guide. Members who received an Opioid Safety Guide were four times more likely to get a prescription of naloxone within 6-months, than did members who had not received the Safety Guide.
Related news
Perspectives
July 25, 2024
Quarterly Drug Pipeline: July 2024
Clinical insights and competitive intelligence on anticipated drugs in development
Perspectives
July 22, 2024
Oncology Insights: 2024 ASCO Annual Meeting key findings
Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions
Perspectives
July 16, 2024
LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast
In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts